DU
CVET

Delphia (USA)’s Covetrus, Inc. Common Stock CVET Stock Holding History

Delphia (USA)’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,764
Closed -$348K – 456
2022
Q2 		$348K Buy
16,764
+4,137
+33% +$73.6K 0.24% 148
2022
Q1 		$212K Buy
+12,627
New +$221K 0.16% 267

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Delphia (USA)'s CVET Position: Q3 2022 in Review

Delphia (USA) sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 16,764 shares — an estimated $348K sold.

Delphia (USA) first reported a position in CVET in Q1 2022 and held it in 2 quarters. The position peaked at $348K in Q2 2022. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Delphia (USA) reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Delphia (USA) sold 16,764 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $348K.
  • Delphia (USA) first reported a position in Covetrus, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Delphia (USA)'s Covetrus, Inc. Common Stock position peaked at $348K in Q2 2022.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Delphia (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.